June 30, 2025 · Form 4 insider transaction
Rolph Timothy bought 890 shares of Akero Therapeutics, Inc. at $23.87 per share, a transaction worth $21.2K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Dr. Rolph is voluntarily reporting the acquisition of these shares on June 30, 2025 pursuant to the Akero Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(c) and Rule 16b-3(d).; In accordance with the provisions of the Akero Therapeutics, Inc. 2019 Employee Stock Purchase Plan, these shares were purchased at 85% of the closing price of the Issuer's common stock on January 2, 2025.